Neutralizing antibodies against the SARS-CoV-2 Omicron variant following two CoronaVac vaccinations and a Pfizer/BioNTech mRNA vaccine booster

Detalles Bibliográficos
Autores principales: da Silva, Almir Ribeiro, Villas-Boas, Lucy Santos, de Paula, Anderson Vicente, Tozetto-Mendoza, Tania Regina, Honorato, Layla, Witkin, Steven S., Mendes-Correa, Maria Cassia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Instituto de Medicina Tropical de São Paulo 2022
Materias:
Letter to the Editor
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9208660/
https://www.ncbi.nlm.nih.gov/pubmed/35730869
http://dx.doi.org/10.1590/S1678-9946202264043

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9208660/
https://www.ncbi.nlm.nih.gov/pubmed/35730869
http://dx.doi.org/10.1590/S1678-9946202264043

Ejemplares similares